(Q35064473)

6 August 2017

title

Novel central nervous system drug delivery systems (English)

1 reference

6 August 2017

1 reference

0 references

Jocelyn Stockwell

1

1 reference

6 August 2017

Nabiha Abdi

2

1 reference

6 August 2017

Xiaofan Lu

3

1 reference

6 August 2017

Oshin Maheshwari

4

1 reference

6 August 2017

Changiz Taghibiglou

5

1 reference

6 August 2017

publication date

14 March 2014

1 reference

Chemical Biology and Drug Design

6 August 2017

published in

1 reference

6 August 2017

volume

83

1 reference

6 August 2017

issue

5

1 reference

6 August 2017

page(s)

507-520

1 reference

Approaches to transport therapeutic drugs across the blood-brain barrier to treat brain diseases

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12268

CNS drug delivery systems: novel approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12268

Blood-brain barrier as a regulatory interface

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12268

Brain meets body: the blood-brain barrier as an endocrine interface

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12268

Structure and function of the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12268

Dynamics of CNS barriers: evolution, differentiation, and modulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12268

Characteristics of compounds that cross the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12268

Recent advances in blood-brain barrier disruption as a CNS delivery strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12268

Delivery of peptides to the brain: emphasis on therapeutic development

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12268

The blood-brain barrier: an overview: structure, regulation, and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12268

Various drug delivery approaches to the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12268

Nanoparticles: a boon to drug delivery, therapeutics, diagnostics and imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12268

New technologies for drug delivery across the blood brain barrier.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12268

Real-time, image-guided, convection-enhanced delivery of interleukin 13 bound to pseudomonas exotoxin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12268

Temporary disruption of the blood-brain barrier by use of ultrasound and microbubbles: safety and efficacy evaluation in rhesus macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12268

Convection-enhanced delivery in the treatment of epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12268

Minimally invasive molecular delivery into the brain using optical modulation of vascular permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12268

Convection-enhanced delivery improves distribution and efficacy of tumor-selective retroviral replicating vectors in a rodent brain tumor model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12268

Convection-enhanced delivery of macromolecules in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12268

Convection-enhanced delivery for the treatment of pediatric neurologic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12268

Drug delivery strategies for the treatment of malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12268

Monoclonal antibody therapy for malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12268

Convection enhanced delivery of macromolecules for brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12268

Convection-enhanced delivery: from mechanisms to clinical drug delivery for diseases of the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12268

Future of convection-enhanced delivery in the treatment of brain tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12268

Convection-enhanced delivery for the treatment of brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12268

Aβ-degrading enzymes: potential for treatment of Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12268

Neurosurgical convection-enhanced delivery of treatments for Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12268

Quantification of convection-enhanced delivery to the ischemic brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12268

Intracerebral infusion of an EGFR-targeted toxin in recurrent malignant brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12268

Novel delivery strategies for glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12268

Positron-emission tomography of vector-mediated gene expression in gene therapy for gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12268

Phase III randomized trial of CED of IL13-PE38QQR vs Gliadel wafers for recurrent glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12268

The use of microbubbles to target drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12268

New strategies to deliver anticancer drugs to brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12268

Ultrasound for drug and gene delivery to the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12268

Targeted delivery of doxorubicin to the rat brain at therapeutic levels using MRI-guided focused ultrasound

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12268

Femtosecond laser disruption of subcellular organelles in a living cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12268

Surgical applications of femtosecond lasers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12268

Targeted transfection by femtosecond laser

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12268

Infrared multiphoton microscopy: subcellular-resolved deep tissue imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12268

Femtosecond near-infrared laser pulses elicit generation of reactive oxygen species in mammalian cells leading to apoptosis-like death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12268

Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12268

Medicinal chemistry based approaches and nanotechnology-based systems to improve CNS drug targeting and delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12268

Large amino acid transporter 1 (LAT1) prodrugs of valproic acid: new prodrug design ideas for central nervous system delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12268

Chemical Aspects of Selective Toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12268

Progress in drug delivery to the central nervous system by the prodrug approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12268

Prodrug approaches for CNS delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12268

Blood-brain barrier delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12268

Current prodrug strategies via membrane transporters/receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12268

Large neutral amino acid transporter enables brain drug delivery via prodrugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12268

Glucose promoiety enables glucose transporter mediated brain uptake of ketoprofen and indomethacin prodrugs in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12268

Transport of amino acid-related compounds mediated by L-type amino acid transporter 1 (LAT1): insights into the mechanisms of substrate recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12268

Brain uptake of ketoprofen-lysine prodrug in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12268

Enkephalin glycopeptide analogues produce analgesia with reduced dependence liability

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12268

Intranasal treatment of central nervous system dysfunction in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12268

Intranasal delivery to the central nervous system: mechanisms and experimental considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12268

Intranasal insulin improves cognition and modulates beta-amyloid in early AD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12268

Intranasal oxytocin improves emotion recognition for youth with autism spectrum disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12268

Intranasal delivery of biologics to the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12268

Nanotechnological advances for the delivery of CNS therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12268

Nanotechnology approaches to crossing the blood-brain barrier and drug delivery to the CNS

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12268

Nanotech approaches to drug delivery and imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12268

Diffusion and mathematical modeling of release profiles from nanocarriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12268

Polymeric nanoparticles for drug delivery to the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12268

A new polymer-lipid hybrid nanoparticle system increases cytotoxicity of doxorubicin against multidrug-resistant human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12268

Transport of polymeric nanoparticle gene carriers in gastric mucus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12268

In vitro and in vivo study of two types of long-circulating solid lipid nanoparticles containing paclitaxel

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12268

Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12268

Novel magnetic/ultrasound focusing system enhances nanoparticle drug delivery for glioma treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12268

The use of cell-penetrating peptides for drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12268

Prediction of cell penetrating peptides by support vector machines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12268

Cell entry of cell penetrating peptides: tales of tails wagging dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12268

Cell-penetrating peptides: from molecular mechanisms to therapeutics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12268

Cell-penetrating peptides as a novel transdermal drug delivery system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12268

Twenty years of cell-penetrating peptides: from molecular mechanisms to therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12268

Cell-penetrating peptides: breaking through to the other side

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12268

Intracellular transduction and potential of Tat PTD and its analogs: from basic drug delivery mechanism to application

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12268

Role of NMDA receptor-dependent activation of SREBP1 in excitotoxic and ischemic neuronal injuries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12268

Therapeutic applications of cell-penetrating peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12268

C-Jun N-terminal kinase regulates adenosine A1 receptor-mediated synaptic depression in the rat hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12268

Cell-penetrating peptides, PepFects, show no evidence of toxicity and immunogenicity in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12268

21 January 2018

Identifiers

DOI

10.1111/CBDD.12268

1 reference

6 August 2017

1 reference